Head and Neck Neoplasms
Conditions
Interventions
This is a Randomized Clinical Trial, with a sample composed of 27 patients who underwent radiotherapy in the treatment of head and neck cancer and who developed trismus. The patients will be allocated
E02.594.540
E02.594
Sponsors
Irmandade Santa Casa de Misericórdia de Porto Alegre
Irmandade Santa Casa de Misericórdia de Porto Alegre
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Adult individuals aged 18 years or older, both sexes, in oncologic follow-up for head and neck cancer treatment at Santa Rita Hospital (ISCMPA) who: have undergone radiotherapy treatment for head and neck cancer; have received medical clearance for treatment with photobiomodulation; have a mouth opening equal to or smaller than 35mm.
Exclusion criteria
Exclusion criteria: Individuals with contraindications for the use of photobiomodulation therapy, according to the manufacturer's manual: history of photosensitivity; use of photosensitive medications or cosmetics; undiagnosed clinical lesions; those who exceed 30% of absences throughout the treatment will be excluded; also excluded will be patients who evolve with clinical instability and sensory oscillation that limits adequate understanding regarding the techniques involved in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The variable regarding the mouth opening measurement refers to the primary endpoint. | — |
Secondary
| Measure | Time frame |
|---|---|
| The variables related to the AMIOFE score, Visual Analog Scale and quality of life questionnaires are part of the secondary endpoints. | — |
Countries
Brazil
Contacts
Public ContactFelipe Goulart
Irmandade Santa Casa de Misericórdia de Porto Alegre
Outcome results
None listed